Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 682 clinical trials
Featured trial
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis

The primary objectives of this study are to evaluate the safety and efficacy of filgotinib in the induction and maintenance treatment of moderately to severely active ulcerative colitis (UC) in

tumor necrosis factor alpha
immunomodulators
vedolizumab
remission
corticosteroids
  • 2136 views
  • 26 Apr, 2019
  • 1 location
Featured trial
Ulcerative Colitis Research Study

Local doctors are looking for people with Ulcerative Colitis for clinical research studies of an investigational medication. Must be receiving treatment for Ulcerative Colitis

ulcerative colitis
  • 954 views
  • 07 Nov, 2020
  • 1 location
Featured trial
DIABETICS WITH FOOT ULCERS

A DIABETIC FOOT ULCER IS AN OPEN SORE OR WOUND THAT OCCURS IN APPROXIMATELY 15 PERCENT OF PATIENTS WITH DIABETES AND IS COMMONLY LOCATED ON THE BOTTOM OF THE FOOT.  

  • 100 views
  • 11 Sep, 2019
  • 1 location
Featured trial
Ulcerative Colitis (UC) Study at ClinSearch

Ulcerative Colitis (UC) is another form of inflammatory bowel disease (IBS). Unlike Crohn’s, which can affect any part of the digestive tract, UC only affects the colon and rectum.

inflammatory bowel disease
  • 95 views
  • 23 Mar, 2022
  • 1 location
Featured trial
ON101CLCT04

Seeking male and female participants 18-80 years of age with type 1 or type 2 diabetes who have a current diabetic foot ulcer.

  • 6 views
  • 08 Aug, 2022
  • 1 location
Featured trial
A Phase 2, Double-Blind, Dose-Ranging, Placebo-Controlled Study With Open-Label Extension to Evaluate the Safety and Efficacy of Itacitinib in Moderate to Severe Ulcerative Colitis

This Phase 2 study is designed to evaluate the efficacy and safety of itacitinib in men and women with moderate to severe UC. The study consists of Part A and Part B, which consist of 12 weeks of double-blind, randomized, placebo-controlled treatment periods followed by 40 weeks open label extension …

vedolizumab
infliximab
corticosteroids
mercaptopurine
endoscopy
  • 78 views
  • 10 May, 2022
  • 5 locations
Featured trial
A Prospective, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial

A Prospective, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial

  • 2264 views
  • 23 Nov, 2020
  • 22 locations
Featured trial
The effect of daily intake of two different doses of Bifidobacterium Breve Bif195 on small-intestinal damage induced by Acetlysalicylic Acid- a randomized, double-blind, placebo-controlled, three-armed, parallel group trial in healthy volunteers.

common causes of peptic ulcer bleeding in developed countries and is associated with a significant increased risk of upper gastrointestinal (GI) bleeding and ulcers.  Live bacteria formulated

  • 848 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Ulcerative Colitis

Ulcerative Colitis

  • 28 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Ulcerative Colitis

Ulcerative Colitis

  • 48 views
  • 25 Mar, 2021
  • 1 location